Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. CUPRIOR (trientine (tétrachlorhydrate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CUPRIOR (trientine (tétrachlorhydrate de))

Medicine - Posted on Jun 11 2019 - Updated on Jun 12 2019
Active substance (DCI)
  • trientine (tétrachlorhydrate de)
history (1)
  • 2/27/19

    CUPRIOR (trientine (tétrachlorhydrate de))

    Intérêt clinique important dans la maladie de Wilson mais pas d’avantage clinique démontré par rapport à TRIENTINE DIHYDROCH...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • A16AX12
Manufacturer
GMP-ORPHAN SA
Presentation

CUPRIOR 150 mg, comprimé (code CIS : 66671295) - Code CIP : 3400930153611

All our publications
    Central nervous system diseases Congenital, genetic and rare diseases Drug therapy Liver diseases Metabolic diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
qdJHr3GdkBKjZ8pQ